View in EDS PDF Full Text

Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib.

Saved in:
Bibliographic Details
Title: Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib.
Authors: Taylor SJ; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia., Duyvestyn JM; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia., Dagger SA; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia., Dishington EJ; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia., Rinaldi CA; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia., Dovey OM; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge CB2 0QQ, UK., Vassiliou GS; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge CB2 0QQ, UK.; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Grove CS; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia.; PathWest Department of Haematology, Queen Elizabeth II Medical Centre, Nedlands, Western Australia 6009, Australia.; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Western Australia 6009, Australia., Langdon WY; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia. wally.langdon@uwa.edu.au.
Source: Science translational medicine [Sci Transl Med] 2017 Aug 09; Vol. 9 (402).
Publication Type: Journal Article
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28794285
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Taylor+SJ%22">Taylor SJ</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Duyvestyn+JM%22">Duyvestyn JM</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Dagger+SA%22">Dagger SA</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Dishington+EJ%22">Dishington EJ</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Rinaldi+CA%22">Rinaldi CA</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Dovey+OM%22">Dovey OM</searchLink>; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge CB2 0QQ, UK.<br /><searchLink fieldCode="AU" term="%22Vassiliou+GS%22">Vassiliou GS</searchLink>; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge CB2 0QQ, UK.; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.<br /><searchLink fieldCode="AU" term="%22Grove+CS%22">Grove CS</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia.; PathWest Department of Haematology, Queen Elizabeth II Medical Centre, Nedlands, Western Australia 6009, Australia.; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Western Australia 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Langdon+WY%22">Langdon WY</searchLink>; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia. wally.langdon@uwa.edu.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101505086%22">Science translational medicine</searchLink> [Sci Transl Med] 2017 Aug 09; Vol. 9 (402).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101505086 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1946-6242 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219466234%22">19466234 </searchLink><i>NLM ISO Abbreviation: </i>Sci Transl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28794285
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1126/scitranslmed.aam8060
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Taylor SJ
      – PersonEntity:
          Name:
            NameFull: Duyvestyn JM
      – PersonEntity:
          Name:
            NameFull: Dagger SA
      – PersonEntity:
          Name:
            NameFull: Dishington EJ
      – PersonEntity:
          Name:
            NameFull: Rinaldi CA
      – PersonEntity:
          Name:
            NameFull: Dovey OM
      – PersonEntity:
          Name:
            NameFull: Vassiliou GS
      – PersonEntity:
          Name:
            NameFull: Grove CS
      – PersonEntity:
          Name:
            NameFull: Langdon WY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 08
              Text: 2017 Aug 09
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1946-6242
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 402
          Titles:
            – TitleFull: Science translational medicine
              Type: main
ResultId 1